Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > Plasma therapy is especially important and last option
View:
Post by StockReddy on Jul 01, 2020 9:52pm

Plasma therapy is especially important and last option

Plasma therapy is especially important and last option to treat and save hundreds of thousands of people’s lives in this health emergency. The good thing is LMNL have expertise in this category and high number of recovered patients from COVID-19 to donor plasma.

 I guess the SP will keep raising based on the performance of the company.

https://stockhouse.com/news/press-releases/2020/06/30/liminal-biosciences-commences-collection-of-convalescent-plasma-from-covid-19

"We are proud to be collecting COVID-19 convalescent plasma to be potentially used in the manufacture of hyperimmune immunoglobulins by third parties and be a part of this historic effort which aims to accelerate a reliable, scalable and sustainable option for patients suffering from the impact of COVID-19.", stated Kenneth Galbraith, Chief Executive Officer of Liminal BioSciences. "We expect that developing a hyperimmune will require third parties to collect plasma donations from many individuals who have fully recovered from COVID-19 and we encourage anyone who has recovered from COVID-19 without symptoms for 14 days to come forward and donate plasma to this worthy cause."

GOOD LUCK TO ALL!
Comment by GoBBs on Jul 01, 2020 10:17pm
LMFAO
Comment by StockReddy on Jul 01, 2020 11:41pm
GoBBS you are unable to see the real picture due to negativity. Jump in or leave the SH and don't check the LMNL SP for this 2 weeks, that way at least you will get some happyness.
Comment by GoBBs on Jul 01, 2020 11:48pm
I know the real picture very well pandocamostockreadymarcjohnson ... but your right I am happier away from this garbage, I need to ditch you losers once and for all. I'll try harder.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities